Moderna increases sales forecast for COVID-19 vaccines to $ 19.2 billion
© Reuters. FILE PHOTO: A healthcare worker holds a vial of Moderna’s COVID-19 vaccine at a pop-up operated by SOMOS Community Care during the coronavirus disease (COVID-19) pandemic in Manhattan in New York City, New York, United States Vaccination center. January 29, 2021.
(Reuters) – Modern (NASDAQ 🙂 Inc raised its 2021 sales forecast for its COVID-19 vaccine by 4.3% to $ 19.2 billion on Thursday, reflecting demand from countries looking to return to normal through rapid vaccination.
Earlier this week, bigger rival Pfizer Inc (NYSE 🙂 expects its COVID-19 vaccine to generate $ 26 billion in sales this year.
Moderna had forecast vaccine sales of $ 18.4 billion in February.
Since then, wealthy nations have stocked shots from Moderna and Pfizer Inc / BioNTech SE after safety concerns and manufacturing issues temporarily suspended vaccines from AstraZeneca (NASDAQ 🙂 Plc and Johnson & Johnson (NYSE :).
For the first quarter ended March 31, Moderna vaccine had sales of $ 1.7 billion.
The company plans to file for full approval of the vaccine in the US this month.
Disclaimer: Fusion Media would like to remind you that the information contained on this website is not necessarily real-time or accurate. All CFDs (stocks, indices, futures) and forex prices are not provided by exchanges, but by market makers. Therefore, prices may not be accurate and may differ from the actual market price. This means that the prices are indicative and not suitable for trading purposes. Therefore, Fusion Media is not responsible for any trading losses you may incur as a result of using this data.
Fusion Media, or anyone involved with Fusion Media, assumes no liability for any loss or damage caused by reliance on the information contained on this website, such as data, offers, charts, and buy / sell signals. Please inform yourself comprehensively about the risks and costs associated with trading in the financial markets. This is one of the riskiest forms of investment possible.